← Back to Search

Behavioral Intervention

Passive Heat Therapy for COPD (COPD Trial)

N/A
Recruiting
Led By Neil Eves, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during procedure: 60-minutes

Summary

This trial tests if hot-water footbaths can help people w/ COPD improve their heart health & reduce blood pressure, by increasing leg blood-flow.

Who is the study for?
This trial is for people over 40 with moderate-to-severe COPD who haven't smoked recently and have been stable for at least 6 weeks. It's not for those on Beta Blockers, in exercise programs, with advanced heart or brain vessel disease, uncontrolled high blood pressure, very low blood pressure, or those frequently using hot baths or saunas.
What is being tested?
The study tests if Passive Heat Therapy (45-minute hot-water footbaths) can improve leg blood-flow and reduce heart disease risk in COPD patients. Over six weeks, the effects of regular footbaths are compared to Sham Immersion (a fake treatment) to see if there are benefits similar to exercising.
What are the potential side effects?
Potential side effects may include discomfort from heat exposure such as sweating or dizziness during the footbath sessions. Long-term side effects are unknown but could involve changes in blood pressure.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during procedure: 60-minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and during procedure: 60-minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mean 24-hour ambulatory blood pressure following chronic passive heat therapy
Secondary study objectives
Arterial stiffness following chronic passive heat therapy
Exercise tolerance following chronic passive heat therapy
Flow mediated dilation of the superficial femoral artery following chronic passive heat therapy.
+2 more
Other study objectives
The acute change in exercise tolerance following a single bout of PHT vs. the change with sham treatment

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Passive Heat TherapyExperimental Treatment1 Intervention
Patients with COPD assigned to passive heat therapy will have their lower legs immersed in a circulating hot water (\~42°C) footbath for 45 min per session.
Group II: Sham ImmersionPlacebo Group1 Intervention
Patients with COPD assigned to the sham condition will have their lower legs immersed in a circulating thermoneutral (\~36°C) footbath for 45 min per session.

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,466 Previous Clinical Trials
2,485,424 Total Patients Enrolled
Canadian Lung AssociationIndustry Sponsor
9 Previous Clinical Trials
65,633 Total Patients Enrolled
Neil Eves, PhDPrincipal InvestigatorAssociate Professor
2 Previous Clinical Trials
83 Total Patients Enrolled

Media Library

Passive Heat Therapy (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05962164 — N/A
Cardiovascular Disease Research Study Groups: Sham Immersion, Passive Heat Therapy
Cardiovascular Disease Clinical Trial 2023: Passive Heat Therapy Highlights & Side Effects. Trial Name: NCT05962164 — N/A
Passive Heat Therapy (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05962164 — N/A
~2 spots leftby Dec 2024